Skip to main content
main-content
Erschienen in: Der Deutsche Dermatologe 5/2022

01.05.2022 | Phototherapie | Fortbildung

Acne inversa

Erscheinungsbild so individuell wie die benötigte Therapie

verfasst von: Dr. med. Michael Schultheis, Ulrike Nikfarjam, Henner Stege, Prof. Dr. med. Stephan Grabbe

Erschienen in: Deutsche Dermatologie | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Auszug

Acne inversa ist eine chronisch rezidivierende inflammatorische Hauterkrankung, die zu einer massiven Krankheitsbelastung führen kann. Die möglichen Behandlungsoptionen umfassen längst nicht mehr nur chirurgische Eingriffe und antibiotische Therapien. Es bedarf einer individuellen Behandlungsplanung, um die oft hohe Krankheitslast bestmöglich zu reduzieren.
Literatur
1.
Zurück zum Zitat Jfri A et al. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis. JAMA Dermatol 2021; 157: 924−31 Jfri A et al. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis. JAMA Dermatol 2021; 157: 924−31
2.
Zurück zum Zitat Zouboulis CC et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015; 29: 619−44 Zouboulis CC et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015; 29: 619−44
3.
Zurück zum Zitat Hurley HJ. Dermatologic surgery, principles and practice. Marcel Dekker, New York 1989: 729−39 Hurley HJ. Dermatologic surgery, principles and practice. Marcel Dekker, New York 1989: 729−39
4.
Zurück zum Zitat Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus: Surgical approach. Marcel Dekker, New York 1996: 623−45 Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus: Surgical approach. Marcel Dekker, New York 1996: 623−45
5.
Zurück zum Zitat Schrader AM et al. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol 2014; 71: 460−7 Schrader AM et al. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol 2014; 71: 460−7
6.
Zurück zum Zitat Matusiak Ł et al. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol 2010; 62: 706−8, 708.e1 Matusiak Ł et al. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol 2010; 62: 706−8, 708.e1
7.
Zurück zum Zitat Tzellos T et al. Impact of hidradenitis suppurativa on work loss, indirect costs and income. Br J Dermatol 2019; 181: 147−54 Tzellos T et al. Impact of hidradenitis suppurativa on work loss, indirect costs and income. Br J Dermatol 2019; 181: 147−54
8.
Zurück zum Zitat Jemec GB. Hidradenitis suppurativa. J Cutan Med Surg 2003; 7: 47−56 Jemec GB. Hidradenitis suppurativa. J Cutan Med Surg 2003; 7: 47−56
9.
Zurück zum Zitat Zouboulis CC et al. What causes hidradenitis suppurativa? 15 years after. Exp Dermatol 2020; 29: 1154−70 Zouboulis CC et al. What causes hidradenitis suppurativa? 15 years after. Exp Dermatol 2020; 29: 1154−70
10.
Zurück zum Zitat Napolitano M et al. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol 2017; 10: 105−15 Napolitano M et al. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol 2017; 10: 105−15
12.
Zurück zum Zitat Kurzen H et al. What causes hidradenitis suppurativa? Exp Dermatol 2008; 17: 455−6; discussion 457−72 Kurzen H et al. What causes hidradenitis suppurativa? Exp Dermatol 2008; 17: 455−6; discussion 457−72
13.
Zurück zum Zitat Magalhães RF et al. Consensus on the treatment of hidradenitis suppurativa − Brazilian Society of Dermatology. An Bras Dermatol 2019; 94 (Suppl 1): 7−19 Magalhães RF et al. Consensus on the treatment of hidradenitis suppurativa − Brazilian Society of Dermatology. An Bras Dermatol 2019; 94 (Suppl 1): 7−19
14.
Zurück zum Zitat Zarchi K et al. Pain and inflammation in hidradenitis suppurativa correspond to morphological changes identified by high-frequency ultrasound. J Eur Acad Dermatol Venereol 2015; 29: 527−32 Zarchi K et al. Pain and inflammation in hidradenitis suppurativa correspond to morphological changes identified by high-frequency ultrasound. J Eur Acad Dermatol Venereol 2015; 29: 527−32
15.
Zurück zum Zitat Vinding GR et al. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol 2014; 170: 884−9 Vinding GR et al. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol 2014; 170: 884−9
16.
Zurück zum Zitat Boer J et al. The Role of Mechanical Stress in Hidradenitis Suppurativa. Dermatol Clin 2016; 34: 37−43 Boer J et al. The Role of Mechanical Stress in Hidradenitis Suppurativa. Dermatol Clin 2016; 34: 37−43
17.
Zurück zum Zitat Pescitelli L et al. Prignano, Hidradenitis suppurativa and associated diseases. G Ital Dermatol Venereol 2018; 153 (Suppl 2): 8−17 Pescitelli L et al. Prignano, Hidradenitis suppurativa and associated diseases. G Ital Dermatol Venereol 2018; 153 (Suppl 2): 8−17
18.
Zurück zum Zitat Goldburg SR et al. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 2020; 82: 1045−58 Goldburg SR et al. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 2020; 82: 1045−58
19.
Zurück zum Zitat Adelon NP. Dictionnaire de médecine: ou, Répertoire général des sciences médicales considérées sous le rapport théorique et pratique. Vol. 2. Béchet, Paris 1839 Adelon NP. Dictionnaire de médecine: ou, Répertoire général des sciences médicales considérées sous le rapport théorique et pratique. Vol. 2. Béchet, Paris 1839
20.
Zurück zum Zitat PubMed Search: Acne inversa OR Akne inversa OR hidradenitis suppurativa. 2022, Januar 25; Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​?​term=​Acne+inversa+ OR+Akne+inversa+OR+hidradenitis+ suppurativa PubMed Search: Acne inversa OR Akne inversa OR hidradenitis suppurativa. 2022, Januar 25; Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​?​term=​Acne+inversa+ OR+Akne+inversa+OR+hidradenitis+ suppurativa
21.
Zurück zum Zitat Zouboulis CC, von Stebut E. [Hidradenitis suppurativa/acne inversa: From "orphan disease" to a curable inflammatory skin disorder]. Hautarzt 2021; 72: 647−50 Zouboulis CC, von Stebut E. [Hidradenitis suppurativa/acne inversa: From "orphan disease" to a curable inflammatory skin disorder]. Hautarzt 2021; 72: 647−50
22.
Zurück zum Zitat Andrade T et al. Hidradenitis suppurativa: epidemiological study of cases diagnosed at a dermatological reference center in the city of Bauru, in the Brazilian southeast State of São Paulo, between 2005 and 2015. An Bras Dermatol 2017; 92: 196−99 Andrade T et al. Hidradenitis suppurativa: epidemiological study of cases diagnosed at a dermatological reference center in the city of Bauru, in the Brazilian southeast State of São Paulo, between 2005 and 2015. An Bras Dermatol 2017; 92: 196−99
23.
Zurück zum Zitat Delany E et al. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP). J Eur Acad Dermatol Venereol 2018; 32: 467−73 Delany E et al. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP). J Eur Acad Dermatol Venereol 2018; 32: 467−73
24.
Zurück zum Zitat Kearney N et al. Complementary and alternative medicine use in hidradenitis suppurativa. Br J Dermatol 2020; 182: 484−5 Kearney N et al. Complementary and alternative medicine use in hidradenitis suppurativa. Br J Dermatol 2020; 182: 484−5
25.
Zurück zum Zitat Zouboulis CC et al. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol 2017; 177: 1401−9 Zouboulis CC et al. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol 2017; 177: 1401−9
26.
Zurück zum Zitat Dessinioti C et al. Hidradenitis suppurrativa (acne inversa) as a systemic disease. Clin Dermatol 2014; 32: 397−408 Dessinioti C et al. Hidradenitis suppurrativa (acne inversa) as a systemic disease. Clin Dermatol 2014; 32: 397−408
27.
Zurück zum Zitat Bördlein I. Onkologie: Wie chronische Entzündungen zu Krebserkrankungen führen. Dtsch Arztebl Internat 2006; 103: A-592 Bördlein I. Onkologie: Wie chronische Entzündungen zu Krebserkrankungen führen. Dtsch Arztebl Internat 2006; 103: A-592
28.
Zurück zum Zitat Kluger N et al. Health-Related Quality of Life of Patients with Hidradenitis Suppurativa Measured with the 15D Instrument and Comparison with the General Population and Patients with Psoriasis. Skin Appendage Disord 2018; 4: 131−5 Kluger N et al. Health-Related Quality of Life of Patients with Hidradenitis Suppurativa Measured with the 15D Instrument and Comparison with the General Population and Patients with Psoriasis. Skin Appendage Disord 2018; 4: 131−5
29.
Zurück zum Zitat Patel ZS et al. Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected]. Curr Pain Headache Rep 2017; 21: 49 Patel ZS et al. Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected]. Curr Pain Headache Rep 2017; 21: 49
30.
Zurück zum Zitat Keary E et al. A qualitative analysis of psychological distress in hidradenitis suppurativa. Br J Dermatol 2020; 182: 342−7 Keary E et al. A qualitative analysis of psychological distress in hidradenitis suppurativa. Br J Dermatol 2020; 182: 342−7
31.
Zurück zum Zitat Sabat R et al. [Acne inversa/hidradenitis suppurativa: An update]. Hautarzt 2017; 68: 999−1006 Sabat R et al. [Acne inversa/hidradenitis suppurativa: An update]. Hautarzt 2017; 68: 999−1006
32.
Zurück zum Zitat Orenstein LAV et al. Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice. Dermatology 2020; 236: 393−412 Orenstein LAV et al. Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice. Dermatology 2020; 236: 393−412
33.
Zurück zum Zitat Zouboulis CC et al. Hidradenitis suppurativa/ acne inversa: a practical framework for treatment optimization − systematic review and recommendations from the HS ALLIANCE working group. J Eur Acad Dermatol Venereol 2019; 33: 19−31 Zouboulis CC et al. Hidradenitis suppurativa/ acne inversa: a practical framework for treatment optimization − systematic review and recommendations from the HS ALLIANCE working group. J Eur Acad Dermatol Venereol 2019; 33: 19−31
34.
Zurück zum Zitat Alikhan A et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol 2019; 81: 76−90 Alikhan A et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol 2019; 81: 76−90
35.
Zurück zum Zitat Scheinfeld N. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients. Dermatol Online J 2013; 19: 1 Scheinfeld N. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients. Dermatol Online J 2013; 19: 1
36.
Zurück zum Zitat Matusiak Ł et al. Clinical Characteristics of Pruritus and Pain in Patients with Hidradenitis Suppurativa. Acta Derm Venereol 2018; 98: 191−4 Matusiak Ł et al. Clinical Characteristics of Pruritus and Pain in Patients with Hidradenitis Suppurativa. Acta Derm Venereol 2018; 98: 191−4
37.
Zurück zum Zitat Senthilnathan A et al. Patient Perceptions of Hidradenitis Suppurativa Stressors. J Dermatolog Treat 2018; 29: 429−30 Senthilnathan A et al. Patient Perceptions of Hidradenitis Suppurativa Stressors. J Dermatolog Treat 2018; 29: 429−30
38.
Zurück zum Zitat Kim ES et al. Adalimumab: A Review in Hidradenitis Suppurativa. Am J Clin Dermatol 2016; 17: 545−52 Kim ES et al. Adalimumab: A Review in Hidradenitis Suppurativa. Am J Clin Dermatol 2016; 17: 545−52
39.
Zurück zum Zitat Haslund P et al. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors. Acta Derm Venereol 2009; 89: 595−600 Haslund P et al. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors. Acta Derm Venereol 2009; 89: 595−600
40.
Zurück zum Zitat Gulliver W et al. Evidence-based approach to the treatment of hidradenitis suppurativa/ acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord 2016; 17: 343−51 Gulliver W et al. Evidence-based approach to the treatment of hidradenitis suppurativa/ acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord 2016; 17: 343−51
41.
Zurück zum Zitat Alikhan A et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol 2019; 81: 91−101 Alikhan A et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol 2019; 81: 91−101
42.
Zurück zum Zitat Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 1998; 39: 971−4 Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 1998; 39: 971−4
43.
Zurück zum Zitat Bettoli V et al. Rates of antibiotic resistance/sensitivity in bacterial cultures of hidradenitis suppurativa patients. J Eur Acad Dermatol Venereol 2019; 33: 930−6 Bettoli V et al. Rates of antibiotic resistance/sensitivity in bacterial cultures of hidradenitis suppurativa patients. J Eur Acad Dermatol Venereol 2019; 33: 930−6
44.
Zurück zum Zitat van der Zee HH et al. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology 2009; 219: 143−7 van der Zee HH et al. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology 2009; 219: 143−7
45.
Zurück zum Zitat van Straalen KR et al. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study. J Am Acad Dermatol 2021; 85: 369−78 van Straalen KR et al. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study. J Am Acad Dermatol 2021; 85: 369−78
46.
Zurück zum Zitat Nikolakis G et al. [Pathogenesis of hidradenitis suppurativa/acne inversa]. Hautarzt 2021; 72: 658−65 Nikolakis G et al. [Pathogenesis of hidradenitis suppurativa/acne inversa]. Hautarzt 2021; 72: 658−65
47.
Zurück zum Zitat Kimball AB et al. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. N Engl J Med 2016; 375: 422−34 Kimball AB et al. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. N Engl J Med 2016; 375: 422−34
48.
Zurück zum Zitat Schneider-Burrus S et al. [Drug therapy of acne inversa]. Hautarzt 2018; 69: 58−63 Schneider-Burrus S et al. [Drug therapy of acne inversa]. Hautarzt 2018; 69: 58−63
49.
Zurück zum Zitat Schultheis M et al. LAight ® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial. Dermatology 2021; https://​doi.​org/​10.​1159/​ 000518540 Schultheis M et al. LAight ® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial. Dermatology 2021; https://​doi.​org/​10.​1159/​ 000518540
50.
Zurück zum Zitat Wilden S et al. Combined treatment of hidradenitis suppurativa with intense pulsed light (IPL) and radiofrequency (RF). J Dermatolog Treat 2021; 32: 530−7 Wilden S et al. Combined treatment of hidradenitis suppurativa with intense pulsed light (IPL) and radiofrequency (RF). J Dermatolog Treat 2021; 32: 530−7
51.
Zurück zum Zitat Nikolakis G. von Stebut E. [Topical and novel device-based therapies for mild hidradenitis suppurativa]. Hautarzt 2021; 72: 676−85 Nikolakis G. von Stebut E. [Topical and novel device-based therapies for mild hidradenitis suppurativa]. Hautarzt 2021; 72: 676−85
53.
Zurück zum Zitat Ellis LZ. Hidradenitis suppurativa: surgical and other management techniques. Dermatol Surg 2012; 38: 517−36 Ellis LZ. Hidradenitis suppurativa: surgical and other management techniques. Dermatol Surg 2012; 38: 517−36
54.
Zurück zum Zitat Bechara FG, Hessam S. Hidradenitis suppurativa. MMW Fortschr Med 2016; 158: 52−3 Bechara FG, Hessam S. Hidradenitis suppurativa. MMW Fortschr Med 2016; 158: 52−3
55.
Zurück zum Zitat Cramer P et al. [Hidradenitis suppurativa/acne inversa-surgical options, reconstruction and combinations with drug therapies - an update]. Hautarzt 2021; 72: 692−9 Cramer P et al. [Hidradenitis suppurativa/acne inversa-surgical options, reconstruction and combinations with drug therapies - an update]. Hautarzt 2021; 72: 692−9
56.
Zurück zum Zitat Velpeau A. Aisselle. In: Dictionnaire de médecine, ou repertoire générale des Sciences Medicals sous le rapport theorique et pratique Un repertoire générale des Sciences Médicals sous le rapport théorique et pratique. Bechet, Paris 1839 Velpeau A. Aisselle. In: Dictionnaire de médecine, ou repertoire générale des Sciences Medicals sous le rapport theorique et pratique Un repertoire générale des Sciences Médicals sous le rapport théorique et pratique. Bechet, Paris 1839
57.
Zurück zum Zitat Kouris A et al. Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa. Dermatology 2016; 232: 687−91 Kouris A et al. Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa. Dermatology 2016; 232: 687−91
58.
Zurück zum Zitat Prussick L et al. Open-label, investigator- initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin- 17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa. Br J Dermatol 2019; 181: 609−11 Prussick L et al. Open-label, investigator- initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin- 17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa. Br J Dermatol 2019; 181: 609−11
59.
Zurück zum Zitat Frew JW et al. The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study. J Am Acad Dermatol 2020; 83: 1341−8 Frew JW et al. The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study. J Am Acad Dermatol 2020; 83: 1341−8
60.
Zurück zum Zitat Megna M et al. Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa. Dermatol Ther 2020; 33: e13756 Megna M et al. Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa. Dermatol Ther 2020; 33: e13756
61.
Zurück zum Zitat Sánchez-Martínez EM et al. Effectiveness and safety of ustekinumab in patients with hidradenitis suppurativa using intravenous induction. Dermatol Ther 2020; 33: e14054 Sánchez-Martínez EM et al. Effectiveness and safety of ustekinumab in patients with hidradenitis suppurativa using intravenous induction. Dermatol Ther 2020; 33: e14054
62.
Zurück zum Zitat Houriet C et al. Canakinumab for Severe Hidradenitis Suppurativa: Preliminary Experience in 2 Cases. JAMA Dermatol 2017; 153: 1195−7 Houriet C et al. Canakinumab for Severe Hidradenitis Suppurativa: Preliminary Experience in 2 Cases. JAMA Dermatol 2017; 153: 1195−7
63.
Zurück zum Zitat André R et al. Long-term therapy with anakinra in hidradenitis suppurativa in three patients. Int J Dermatol 2019; 58: e208−9 André R et al. Long-term therapy with anakinra in hidradenitis suppurativa in three patients. Int J Dermatol 2019; 58: e208−9
Metadaten
Titel
Acne inversa
Erscheinungsbild so individuell wie die benötigte Therapie
verfasst von
Dr. med. Michael Schultheis
Ulrike Nikfarjam
Henner Stege
Prof. Dr. med. Stephan Grabbe
Publikationsdatum
01.05.2022
Verlag
Springer Medizin
Erschienen in
Deutsche Dermatologie / Ausgabe 5/2022
Print ISSN: 2731-7692
Elektronische ISSN: 2731-7706
DOI
https://doi.org/10.1007/s15011-022-4963-5

Weitere Artikel der Ausgabe 5/2022

Der Deutsche Dermatologe 5/2022 Zur Ausgabe

Neu im Fachgebiet Dermatologie

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Dermatologie und bleiben Sie gut informiert – ganz bequem per eMail.